Lexicon Pharmaceuticals Inc Revenue per Employee (LXRX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lexicon Pharmaceuticals Inc   (NASDAQ: LXRX)
 

Lexicon Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Lexicon Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 475,765, below the company average number of $774,858.
Within the Healthcare sector Employees of 95 other companies have achieved higher revenue per employee. While Lexicon Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 904 to 1008. Lexicon Pharmaceuticals Inc has 81 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LXRX Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change -20.67 % -97.6 % 1572.11 % -79.31 % 710.4 %
Sales per Employee (TTM) $ 475,765 511,963 859,790 614,852 874,864
LXRX's Total Ranking # 1008 # 904 # 2001 # 1991 #
Seq. Revenue Change 1525.72 % -96.72 % 284.16 % -61.27 % -50.87 %

LXRX Company Profile >> Back to LXRX Efficiency Comparisons >> Compare LXRX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 69
Healthcare Sector # 96
Overall Market # 1008

Revenue per Employee Statistics
High Average Low
$ 4,079,222 $ 774,858 $ 1,556
(Sep 30 2019)   (Mar 31 2023)



Financial Statements
Lexicon Pharmaceuticals Inc 's Revenue MRQ $ 11 Millions Visit LXRX's Income Statement
Lexicon Pharmaceuticals Inc 's Revenues TTM $ 39 Millions Visit LXRX's aggregate revenue growth
What are LXRX's Sales? Visit LXRX's Sales by Segment




Other Ratios
Lexicon Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LXRX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LXRX's Competitors
Revenue per Employee for LXRX's Suppliers
Revenue per Employee for LXRX's Customers

You may also want to know
LXRX's Sales Growth Rates LXRX's Pe Price to earnings ratio LXRX's Receivables Turnover Ratio LXRX's Stock Quote
LXRX's Net Income Growth Rates LXRX's Ps Price to Sales ratio LXRX's Sales per Employee LXRX's Asset Turnover Ratio
LXRX's Net Margin LXRX's Pb Price to Book ratio LXRX's Financial Strength Ratios LXRX's Dividend Payout Ratio
Date modified: 2026-11-09T06:44:39+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Transmedics Group Inc   810,300.67 $ 727.650  Million 898 
Cerus Corporation  787,493.06 $ 226.798  Million 288 
Ars Pharmaceuticals Inc   749,300.61 $ 122.136  Million 163 
Phathom Pharmaceuticals Inc   740,919.14 $ 274.881  Million 371 
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Mannkind Corporation  698,260.14 $ 413.370  Million 592 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Novavax inc   549,598.13 $ 411.649  Million 749 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Lexicon Pharmaceuticals Inc   475,765.43 $ 38.537  Million 81 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Monte Rosa Therapeutics Inc   468,833.33 $ 70.325  Million 150 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Haemonetics Corporation  457,405.56 $ 1,382.737  Million 3,023 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.